Niagen Bioscience Announces Participation in Upcoming Investor Conferences

LOS ANGELES–(BUSINESS WIRE)—- $NAGE #Biotech–Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior leadership will participate in the following upcoming conferences: 31st Annual Sohn Investment Conference Location: Jazz at Lincoln Center’s Frederick P….
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks